Table 1.
CALB2+ parent axon and calyx densities.
Treatment | Density (units/100 μm2) |
|||||
---|---|---|---|---|---|---|
CALB2+ calyx |
CALB2+ parent axon |
|||||
Horizontal | Posterior | Superior | Horizontal | Posterior | Superior | |
Normal | 0.41 ± 0.009 (N = 3) | 0.47 ± 0.027 (N = 3) | 0.44 ± 0.054 (N = 3) | 0.19 ± 0.023 (N = 3) | 0.24 ± 0.038 (N = 3) | 0.18 ± 0.046 (N = 3) |
Vehicle control | 0.35 ± 0.036 (N = 3) | 0.50 ± 0.035 (N = 3) | 0.46 ± 0.023 (N = 3) | 0.19 ± 0.018 (N = 3) | 0.27 ± 0.019 (N = 3) | 0.23 ± 0.011 (N = 3) |
Contralesion control | 0.36 ± 0.039 (N = 5) | 0.47 ± 0.043 (N = 8) | 0.46 ± 0.084 (N = 5) | 0.20 ± 0.019 (N = 5) | 0.27 ± 0.033 (N = 8) | 0.21 ± 0.033 (N = 5) |
Combined control | 0.37 ± 0.039 (N = 11) | 0.48 ± 0.045 (N = 14) | 0.45 ± 0.060 (N = 11) | 0.19 ± 0.019 (N = 11) | 0.26 ± 0.031 (N = 14) | 0.21 ± 0.035 (N = 11) |
0.5 month | 0.12 ± 0.210∗ (N = 3) | 0.19 ± 0.320∗∗∗ (N = 3) | 0.18 ± 0.311∗∗ (N = 3) | 0.20 ± 0.032 (N = 3) | 0.26 ± 0.014 (N = 3) | 0.21 ± 0.021 (N = 3) |
1 month | 0.11 ± 0.186 (N = 3) | 0.11 ± 0.172∗∗ (N = 3) | 0.12 ± 0.200∗ (N = 3) | 0.17 ± 0.044 (N = 3) | 0.23 ± 0.031 (N = 3) | 0.20 ± 0.028 (N = 3) |
2 months | 0.00 ± 0.000∗∗∗ (N = 3) | 0.00 ± 0.000∗∗∗ (N = 3) | 0.00 ± 0.000∗∗∗ (N = 2) | 0.15 ± 0.009 (N = 3) | 0.22 ± 0.035 (N = 3) | 0.20 ± 0.037 (N = 2) |
6 months | 0.00 ± 0.000∗∗∗ (N = 3) | 0.00 ± 0.000∗∗∗ (N = 4) | 0.01 ± 0.015∗∗∗ (N = 4) | 0.19 ± 0.019 (N = 3) | 0.23 ± 0.027 (N = 4) | 0.17 ± 0.054 (N = 4) |
All values are means ± SD. N, number of specimens. Significance values represent comparisons with combined controls. These data complement the relative densities depicted in Figure 8. Asterisks correspond to: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.